2-(3-(3-chloro-2,5-difluorophenyl)-3-azaspiro[5.5]undecan-9-yl)acetic acid

ID: ALA3901994

PubChem CID: 73777175

Max Phase: Preclinical

Molecular Formula: C18H22ClF2NO2

Molecular Weight: 357.83

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(O)CC1CCC2(CC1)CCN(c1cc(F)cc(Cl)c1F)CC2

Standard InChI:  InChI=1S/C18H22ClF2NO2/c19-14-10-13(20)11-15(17(14)21)22-7-5-18(6-8-22)3-1-12(2-4-18)9-16(23)24/h10-12H,1-9H2,(H,23,24)

Standard InChI Key:  GVMZIQCXQRZWJK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   11.4586   -5.5518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7424   -5.1419    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.8757  -10.4980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8903   -6.3726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1737   -7.6090    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1755   -5.1349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8648  -12.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1531  -11.7316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8859   -8.8509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8589  -12.9745    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4485  -10.4882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8821   -9.6713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1590  -10.9064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6044   -6.7865    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.4616   -8.8509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1737   -6.7838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5824  -11.7417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8907   -5.5482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8859   -8.0257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1700   -9.2593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4616   -8.0257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4532   -9.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4618   -6.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5988   -5.1400    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  8  7  1  0
 11 13  1  0
  6  1  1  0
 16  4  2  0
  3 12  1  0
 22 11  1  0
 20  9  1  0
 20 22  1  0
  4 18  1  0
  7 17  1  0
 15 20  1  0
  1  2  1  0
 21  5  1  0
 19  5  1  0
 13  8  1  0
 20 12  1  0
  5 16  1  0
  9 19  1  0
 13  3  1  0
  7 10  2  0
 23 16  1  0
 18  6  2  0
  4 14  1  0
 21 15  1  0
  1 23  2  0
 18 24  1  0
M  END

Associated Targets(Human)

FFAR4 Tchem G-protein coupled receptor 120 (2999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR1 Tchem Free fatty acid receptor 1 (4763 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ffar4 Omega-3 fatty acid receptor 1 (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 357.83Molecular Weight (Monoisotopic): 357.1307AlogP: 4.87#Rotatable Bonds: 3
Polar Surface Area: 40.54Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.63CX Basic pKa: CX LogP: 4.69CX LogD: 1.99
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: -0.60

References

1. Cox JM, Chu HD, Chelliah MV, Debenham JS, Eagen K, Lan P, Lombardo M, London C, Plotkin MA, Shah U, Sun Z, Vaccaro HM, Venkatraman S, Suzuki T, Wang N, Ashley ER, Crespo A, Madeira M, Leung DH, Alleyne C, Ogawa AM, Souza S, Thomas-Fowlkes B, Di Salvo J, Weinglass A, Kirkland M, Pachanski M, Powles MA, Tozzo E, Akiyama TE, Ujjainwalla F, Tata JR, Sinz CJ..  (2017)  Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists.,  (1): [PMID:28105274] [10.1021/acsmedchemlett.6b00360]

Source